BioGenes Is Your Partner for Routine and Sophisticated Projects
BioGenes Is Your Partner for Routine and Sophisticated Projects

BioGenes now offers PK and immunogenicity products and services

BioGenes now offers anti-drug antibodies against Adalimumab and Infliximab (polyclonal and monoclonal) as well as pre-qualified immunogenicity and PK ELISAs for Adalimumab and Infliximab biosimilar studies.

Our custom services include:

  • Development of monoclonal (for PK ELISA) or polyclonal (as control for immunogenicity studies) antibodies against your biosimilar, including production and pair search
  • Development and qualification of PK and immunogenicity ELISAs, based on our optimized technology

Our preferred partner for validation and sample determination is Eurofins Munich. However, a transfer of the ELISA to you, or your CRO is possible.

Please find more information here:

If you would like to get an offer, please fill in the questionnaire or contact us.